---
document_datetime: 2023-09-21 21:31:03
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/livmarli-epar-all-authorised-presentations_en.pdf
document_name: livmarli-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.651906
conversion_datetime: 2025-12-23 06:26:41.01304
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                                                                             |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|---------------------------------------------------------------------------------------|
| EU/1/22/1704/001 | LIVMARLI          | 9.5 mg/ml  | Oral solution         | Oral use                  | bottle (PET)          | 30 ml                     | 1 bottle + 1 oral syringe of 0.5 ml + 1 oral syringe of 1 ml + 1 oral syringe of 3 ml |